DHT and Hair Loss in Men - UK Pharmacy Guide

Understanding dht and hair loss in men is the first step to choosing an effective treatment for male pattern baldness. Dihydrotestosterone (DHT) is the androgen hormone that binds to receptors in genetically susceptible hair follicles, causing progressive miniaturisation and the characteristic receding hairline and crown thinning seen in androgenetic alopecia. At Cured Pharmacy, our UK-registered clinical team helps thousands of men access evidence-based DHT-blocking treatments, all supplied with transparent pricing and discreet next-day delivery after a free online consultation.

What Is DHT and Hair Loss in Men?

DHT (dihydrotestosterone) is a potent androgen formed when the enzyme 5-alpha reductase converts testosterone in the scalp and prostate. In men with androgenetic alopecia, hair follicles on the scalp carry a genetic sensitivity to DHT: the hormone binds to androgen receptors in the dermal papilla, triggering a cascade that shortens the anagen (growth) phase and shrinks the follicle over successive cycles [1]. This process, called miniaturisation, transforms thick terminal hairs into fine vellus hairs and eventually leads to visible thinning and baldness.

Male pattern hair loss follows a predictable pattern—temple recession and vertex thinning—because follicles in these zones express higher levels of androgen receptors and 5-alpha reductase type II [2]. Follicles at the back and sides of the scalp are largely DHT-resistant, which is why hair transplant surgeons harvest donor grafts from these areas. Crucially, dht and hair loss in men is not an all-or-nothing phenomenon: the degree of sensitivity varies, which is why some men lose hair rapidly in their twenties while others retain density into later life.

• DHT is five times more potent than testosterone at binding androgen receptors in scalp follicles
• Miniaturisation is progressive—each hair cycle produces a thinner, shorter hair until the follicle becomes dormant
• Genetic factors determine both the age of onset and the rate of progression in male pattern baldness

How DHT and Hair Loss in Men Progresses Over Time

The link between dht and hair loss in men unfolds over years, not weeks. In the earliest stages, men may notice increased shedding or a subtle recession at the temples. As DHT continues to act on susceptible follicles, the anagen phase shortens from several years to just months, and the hair shaft diameter decreases by up to 50 per cent [1]. Eventually, miniaturised follicles produce hairs so fine they no longer emerge through the scalp surface, creating the appearance of baldness even though the follicle remains biologically alive.

Without intervention, androgenetic alopecia typically advances from Norwood stage I (minimal recession) to stage VI or VII (extensive vertex and frontal loss) over two to three decades. The rate of progression is highly individual: some men plateau at a Norwood III vertex pattern, while others experience rapid diffuse thinning. Clinical trials confirm that earlier intervention—ideally before significant miniaturisation—yields better cosmetic outcomes, because once a follicle has been dormant for several years, reversal becomes increasingly unlikely [2].

The Role of 5-Alpha Reductase Enzymes

Two isoforms of 5-alpha reductase exist: type I (sebaceous glands, liver) and type II (hair follicles, prostate). Finasteride selectively inhibits type II, reducing scalp DHT by approximately 60–70 per cent, while dutasteride inhibits both isoforms and achieves a 90 per cent reduction in serum DHT [3]. This dual inhibition explains why dutasteride, though used off-label for hair loss in the UK, shows superior hair-count gains in head-to-head trials, albeit with a similar side-effect profile.

Evidence-Based Treatments for DHT and Hair Loss in Men

The cornerstone of medical management for dht and hair loss in men is pharmacological DHT suppression. Finasteride 1mg (Propecia and generic) is the only oral treatment licensed in the UK specifically for male pattern baldness. In pivotal five-year trials, finasteride increased scalp hair count by an average of 10 per cent at the vertex and halted further loss in 90 per cent of men [1]. Visible improvement typically emerges after three to six months of daily use, and continued treatment is essential to maintain benefit—discontinuation leads to reversal within 12 months.

Topical minoxidil 5% (Regaine Extra Strength Foam) works by a complementary mechanism: it prolongs anagen, increases follicle size, and stimulates vascular endothelial growth factor (VEGF) in the dermal papilla [4]. Because minoxidil does not block DHT, combining it with finasteride addresses hair loss via two independent pathways, and meta-analyses confirm additive efficacy. Dutasteride 0.5mg, licensed in the UK for benign prostatic hyperplasia, is prescribed off-label by some UK clinicians for men who show suboptimal response to finasteride; prescribers weigh the greater DHT suppression against the identical regulatory cautions around sexual and mood-related side effects.

1. Start with finasteride 1mg daily if you want systemic DHT blockade with the strongest evidence base
2. Add topical minoxidil 5% foam twice daily for synergistic growth-phase stimulation
3. Consider dutasteride 0.5mg off-label only after discussion with a UK prescriber if finasteride proves insufficient
4. Monitor progress with standardised photographs every three months to assess miniaturisation reversal objectively

DHT-Blocking Hair Loss Treatments at Cured Pharmacy

Safety and Side Effects of DHT-Blocking Treatments

Finasteride and dutasteride are generally well tolerated, but the MHRA requires clear counselling on potential adverse effects. In clinical trials, 1.3–1.8 per cent of men taking finasteride 1mg reported decreased libido, erectile dysfunction, or ejaculatory disorders, versus 0.9–1.2 per cent on placebo [1]. Most cases resolve on continued treatment or after discontinuation, but persistent sexual dysfunction has been reported in a small subset of users. The MHRA also advises that mood changes, including low mood and, very rarely, suicidal ideation, have been reported; patients should seek medical advice if they experience these symptoms [5].

Dutasteride carries identical warnings, reflecting its mechanism of action. Because both drugs can be absorbed through the skin, women who are or may become pregnant must not handle crushed or broken tablets due to the risk of feminisation of a male foetus. Topical minoxidil is associated with scalp irritation in about 5 per cent of users and transient increased shedding in the first two to eight weeks—this 'minoxidil shed' reflects the synchronisation of follicles into anagen and is a positive prognostic sign [4]. All prescription treatments at Cured Pharmacy are supplied only after a free online consultation reviewed by a UK-registered prescriber, ensuring suitability and safety for each individual.

Monitoring and When to Seek Advice

Men using finasteride or dutasteride should be aware that these drugs lower serum prostate-specific antigen (PSA) by approximately 50 per cent after six months. If you require PSA screening, inform your GP so the result can be doubled for accurate interpretation [3]. Report any new breast lump, nipple discharge, or persistent sexual or mood symptoms to your prescriber promptly. Regular follow-up—typically at three, six, and twelve months—helps track efficacy and tolerability, and our pharmacist-led service at Cured Pharmacy includes ongoing support throughout your treatment journey.

Accessing Treatment for DHT and Hair Loss in Men at Cured Pharmacy

Cured Pharmacy (GPhC 9012511) is a UK-registered online pharmacy led by superintendent pharmacist Tarun Kumar (GPhC 2233073). We supply genuine, UK-licensed finasteride, dutasteride, and minoxidil with transparent upfront pricing—finasteride 1mg starts from £12.49 for 28 tablets, and our Hair Loss Combo Pack (finasteride plus minoxidil foam) is priced from £34.99 for one month [6]. Every order includes a free clinical consultation completed in under three minutes; a UK prescriber reviews your answers and, if appropriate, issues a prescription electronically to our dispensary.

We offer discreet, plain packaging and next-day delivery across the UK, and first-time customers save 20 per cent with code Hairlossnew at checkout. Understanding dht and hair loss in men empowers you to make an informed choice, and our clinical team is available by phone (+44 116 4646009) to answer questions about treatment options, side effects, or how to optimise your regimen. Because male pattern baldness is progressive, starting evidence-based therapy sooner rather than later maximises your chance of preserving—and potentially regrowing—hair.

• Transparent pricing displayed before you begin the consultation—no hidden fees or subscription traps
• UK-registered prescribers and pharmacists review every order for safety and suitability
• Discreet next-day delivery in plain, unmarked packaging to any UK address
• 20 per cent discount on your first order when you use code Hairlossnew
• Ongoing support and repeat-prescription service to ensure treatment continuity

Scientific references

1. Kaufman, K. D., Olsen, E. A., Whiting, D., Savin, R., DeVillez, R., Bergfeld, W., … & Swinehart, J. (1998). Finasteride in the treatment of men with androgenetic alopecia. Journal of the American Academy of Dermatology, 39(4), 578–589. https://pubmed.ncbi.nlm.nih.gov/9777765/ [accessed 28 October 2026]
2. Sinclair, R., Patel, M., Dawson, T. L., Yazdabadi, A., Yip, L., Perez, A., & Rufaut, N. W. (2015). Hair loss in men: androgens and therapeutic strategies. Journal of Investigative Dermatology Symposium Proceedings, 17(1), 14–17. https://doi.org/10.1038/jidsymp.2015.6 [accessed 28 October 2026]
3. Gupta, A. K., & Charrette, A. (2014). The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit–risk assessment of finasteride and dutasteride. Journal of Dermatological Treatment, 25(2), 156–161. https://doi.org/10.3109/09546634.2013.813011 [accessed 28 October 2026]
4. Messenger, A. G., & Rundegren, J. (2004). Minoxidil: mechanisms of action on hair growth. British Journal of Dermatology, 150(2), 186–194. https://pubmed.ncbi.nlm.nih.gov/14996087/ [accessed 28 October 2026]
5. Medicines and Healthcare products Regulatory Agency. (2017). Finasteride 1 mg for male pattern hair loss: reminder of the risk of psychiatric and sexual adverse reactions. Drug Safety Update, 11(3). https://www.gov.uk/drug-safety-update/finasteride-1-mg-for-male-pattern-hair-loss-reminder-of-the-risk-of-psychiatric-and-sexual-adverse-reactions [accessed 28 October 2026]
6. Cured Pharmacy. (2025). Hair Loss Treatments – Finasteride, Dutasteride & Minoxidil. Retrieved from https://curedpharmacy.com/collections/hair-loss https://curedpharmacy.com/collections/hair-loss [accessed 28 October 2026]
7. NHS. (2026). Hair loss. https://www.nhs.uk/conditions/hair-loss/ [accessed 28 October 2026]
8. NHS. (2026). Finasteride: a medicine to treat an enlarged prostate and male pattern baldness. https://www.nhs.uk/medicines/finasteride/ [accessed 28 October 2026]